(Q47800561)

5 February 2018

title

What hypofractionated protocols should be tested for prostate cancer? (English)

1 reference

5 February 2018

1 reference

Jack F Fowler

1

1 reference

5 February 2018

Mark A Ritter

series ordinal

2

1 reference

5 February 2018

Rick J Chappell

series ordinal

3

1 reference

5 February 2018

David J Brenner

series ordinal

4

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 July 2003

1 reference

5 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

5 February 2018

volume

56

1 reference

5 February 2018

issue

4

1 reference

5 February 2018

page(s)

1093-1104

1 reference

5 February 2018

Fractionation and protraction for radiotherapy of prostate carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Is the prostrate alpha/beta ratio of 1.5 from Brenner & Hall a modeling artifact

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Is alpha/beta for prostate tumors really low?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Is the alpha/beta for prostate tumors really low? In regard to Fowler et al., IJROBP 2001;50:1021-1031.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Toward optimal external-beam fractionation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

The prospects for new treatments for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Fractionation in medium dose rate brachytherapy of cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Sublethal damage repair times for a late-responding tissue relevant to brachytherapy (and external-beam radiotherapy): implications for new brachytherapy protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Dose selection for prostate cancer patients based on dose comparison and dose response studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

On using the linear-quadratic model in daily clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

The simultaneous boost technique: the concept of relative normalized total dose

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Cell cycle and growth response of CHO cells to X-irradiation: threshold-free repair at low doses

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

The influence of autologous tumor fibroblasts on the radiosensitivity of squamous cell carcinoma megacolonies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

How low is the alpha/beta ratio for prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Radiation tolerance of the rat rectum to fractionated X-rays and pi-mesons

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

The effect of cis-diamminedichloroplatinum(II) on radiation damage in mouse rectum after fractionated irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

RBE values and repair characteristics for colo-rectal injury after caesium 137 gamma-ray and neutron irradiation. II. Fractionation up to ten doses

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Early and late injuries in mouse rectum after fractionated X-ray and neutron irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Consequential late effects in normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900132-9

7 January 2021

10.1016/S0360-3016(03)00132-9

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

12829147

1 reference

5 February 2018